본문으로 건너뛰기
← 뒤로

Integrated computational and biological assessment of novel piperazine and piperidine-substituted 1,2,4-oxadiazoles for lung cancer therapy.

2/5 보강
Future medicinal chemistry 2026 p. 1-10 Computational Drug Discovery Methods
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-29
OpenAlex 토픽 · Computational Drug Discovery Methods Synthesis and biological activity Cancer therapeutics and mechanisms

Kumar D, Jangir M, Chaurasia A

📝 환자 설명용 한 줄

[AIMS] To design and synthesize a novel series of piperazine- and piperidine-substituted 1,2,4-oxadiazole derivatives and evaluate their anticancer potential, with particular interest in possible inte

이 논문을 인용하기

↓ .bib ↓ .ris
APA D P. Kumar, Mukesh Jangir, Arti Chaurasia (2026). Integrated computational and biological assessment of novel piperazine and piperidine-substituted 1,2,4-oxadiazoles for lung cancer therapy.. Future medicinal chemistry, 1-10. https://doi.org/10.1080/17568919.2026.2658008
MLA D P. Kumar, et al.. "Integrated computational and biological assessment of novel piperazine and piperidine-substituted 1,2,4-oxadiazoles for lung cancer therapy.." Future medicinal chemistry, 2026, pp. 1-10.
PMID 41989277

Abstract

[AIMS] To design and synthesize a novel series of piperazine- and piperidine-substituted 1,2,4-oxadiazole derivatives and evaluate their anticancer potential, with particular interest in possible interaction with the epidermal growth factor receptor (EGFR).

[MATERIALS AND METHODS] The target compounds were synthesized using established heterocyclic strategies and characterized by standard spectroscopic techniques. Molecular docking studies were performed using the EGFR tyrosine kinase domain (PDB ID: 3OW4) to predict binding modes and ligand-receptor interactions. In vitro cytotoxic activity was assessed against A549 human lung carcinoma cells using the MTT assay.

[RESULTS] Docking analysis suggested favorable binding orientations within the EGFR ATP-binding site and predicted interactions with key amino acid residues. studies demonstrated dose-dependent antiproliferative activity for all compounds. Among them, compound exhibited the highest activity, with an IC value of 26.98 µM.

[CONCLUSIONS] The synthesized 1,2,4-oxadiazole derivatives display moderate antiproliferative activity and represent preliminary lead structures for further optimization. While molecular modeling suggests potential EGFR interaction, additional biochemical studies are required to confirm the precise mechanism of action.

같은 제1저자의 인용 많은 논문 (5)